Cann Group Limited (CNGGF)
Cann Group Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Mildura, VIC, AU. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $3.3M. On trailing twelve-month figures it carries a trailing P/E of 0.30, a net margin of 237.1%. Its beta of 0.11 implies it has historically moved less than the broad market.
Cann Group Limited specializes in the end-to-end process of bringing medicinal cannabis to market. Its activities span from genetic development and cultivation to product manufacturing, clinical trials, and ultimately, the supply of therapeutic cannabis for both Australian consumption and international export. The company holds specific licenses enabling it to conduct research and grow cannabis for human medicinal and scientific study. Founded in 2014, Cann Group Limited operates out of its base in Port Melbourne, Australia.
Cann Group Limited is most often compared with the following Healthcare names: